SMAD2 and cancer: However, in the cancer microenvironment, a high level of TSP-2 produced by cancer-associated fibroblasts is activated via the TGF-β1/Smad2/3 pathway, binds to integrin αvβ3/CD36 and activates the MAPK pathway in cancer cells to promote tumor growth and adhesion (28).